CONSIDERATIONS TO KNOW ABOUT LAS17

), can help to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only every time they have been independently inhibited, lending assistance to your proposal that a combination drug therapy concentrating on these motors may be a workable method for beatin